Table 2 Statistical analysis showing the effect of optimal nutraceutical combination on PCOS phenotypes in the obese PCOS population
PCOS characteristics | Clinical parameters | Obese PCOS control group* | Obese PCOS intervention group* | p-value |
|---|---|---|---|---|
Polycystic ovaries | Pre antral follicle (count) | 30.80 (2.64) | 18.64 (2.14) | < 0.0001 |
Anovulation | Cycle length (days) | 37.52 (1.14) | 34.10 (1.04) | < 0.0001 |
Oligomenorrhea | LH (IU/L) | 199.73 (22.44) | 129.87 (15.13) | < 0.0001 |
Infertility | Estradiol (pg/ml) | 386.09 (35.10) | 251.87 (27.12) | < 0.0001 |
Hirsutism | Testosterone (ng/dl) | 61.96 (4.62) | 46.08 (3.13) | < 0.0001 |
Infertility | AMH (ng/ml) | 4.18 (0.52) | 1.79 (0.42) | < 0.0001 |
Lean/Obese PCOS | Triglycerides (mg/dl) | 167.71 (11.97) | 126.59 (8.12) | < 0.0001 |